Literature DB >> 24088906

Surgical resection of a solitary plasmacytoma originating in a rib.

Kouhei Tajima1, Nobuyuki Uchida, Yoko Azuma, Toshiyuki Okada, Hajime Sasamoto, Hideaki Yokoo, Hiroyuki Kuwano.   

Abstract

Plasma cell neoplasms can present as a single lesion (solitary plasmacytoma) or as multiple lesions (multiple myeloma). Solitary plasmacytoma is a rare plasma cell neoplasm. There are 2 separate entities, dependent on the location of the lesion originating in either bone or extramedullary soft tissue. It is defined as a proliferation of monoclonal plasma cells without evidence of significant bone-marrow plasma-cell infiltration. We present a 71-year-old woman who was diagnosed with a solitary plasmacytoma of the bone located in the right third rib after surgical resection. A chest roentgenogram showed a solitary expanding lesion in the right third rib. Chest computed tomography (CT) revealed an osteolytic chest wall tumor. Fluorodeoxyglucose positron emission tomography and CT (PET-CT) showed no abnormal uptake in the whole body, except for the third rib lesion. The patient underwent complete en-bloc resection of the chest wall including ribs, muscle, and parietal pleura. The patient is asymptomatic without any recurrence after one and a half years of follow up.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24088906     DOI: 10.5761/atcs.cr.12-02235

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  2 in total

1.  Solitary plasmacytoma of the left rib misdiagnosed as angina pectoris: A case report.

Authors:  Jian Yao; Xu He; Cheng-Yuan Wang; Li Hao; Li-Li Tan; Chun-Jian Shen; Ming-Xiao Hou
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

Review 2.  Surgery combined with radiotherapy for the treatment of solitary plasmacytoma of the rib: a case report and review of the literature.

Authors:  Rui Jia; Lei Xue; Huagang Liang; Kun Gao; Jian Li; Zhefeng Zhang
Journal:  J Cardiothorac Surg       Date:  2015-10-13       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.